Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy.
نویسندگان
چکیده
منابع مشابه
Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.
BACKGROUND The management of bisphosphonate-related osteonecrosis of the jaws (BRONJ) is challenging and controversial. At present, there is no established medication treatment for the disease. METHODS A 78-year-old osteoporotic woman with osteonecrosis of the mandible related to alendronate therapy was referred for treatment. The disease was unresponsive to conservative therapy, including an...
متن کاملResolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant
3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D.
متن کاملRole of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
While the optimal treatment concept of medication-related osteonecrosis of the jaws (MRONJ) is still in debate, several adjunct therapies have been introduced. Among these adjunctive measures, recombinant human parathyroid hormone (rhPTH, teriparatide) seems to be the most promising treatment modality. Several studies have presented the beneficial effect of short-term teriparatide; they have sh...
متن کاملCould teriparatide be the treatment for osteonecrosis of the jaws?
To the Editor: We read with great interest the case reported by Lee et al in the Early View section of the journal, presenting a case of aledronate-induced osteonecrosis of the jaws (ONJ), which healed following teriparatide administration. The authors conclude that teriparatide can be an important adjuvant to other measures in the management of ONJ that should be considered prior to major rese...
متن کاملPARATHYROID HORMONE AND TERIPARATIDE FOR THE TREATMENT OF OSTEOPOROSIS: A REVIEW OF THE EVIDENCE AND SUGGESTED GUIDELINES FOR ITS USE. Corresponding Author
All therapies currently recommended for the management of osteoporosis act mainly to inhibit bone resorption and reduce bone remodeling. Parathyroid hormone and its analog, teriparatide (recombinant human PTH(1-34), represent a new class of anabolic therapies for the treatment of severe osteoporosis, having the potential to improve skeletal micro-architecture. Significant reductions in both ver...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of rheumatology
دوره 36 8 شماره
صفحات -
تاریخ انتشار 2009